Form 10-Q INOVIO PHARMACEUTICALS, For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
Aegis Capital Comments on Inovio (INO) Following Q2 Results; Cash Position Remains 'Solid'
August 11, 2014 11:05 AM EDTAegis Capital affirms Inovio Pharmaceuticals (AMEX: INO) at Buy with a target price of $19 following Q2 results and update released earlier Monday.
Analyst Ram Selvaraju commented, This morning, Inovio reported financial results for the second quarter of 2014. The firm closed the... More
Inovio Pharmaceuticals (INO) Posts Narrower than Expected Q2 Loss of 18c/Share
August 11, 2014 9:17 AM EDTInovio Pharmaceuticals, Inc. (AMEX: INO) reported Q2 EPS of ($0.18), $0.01 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $1.8 million.
Dr. J. Joseph Kim, President and CEO, said, "Our second quarter marked a historical... More
